Import life-saving medicines not yet approved in India under the regulatory Named Patient Import program by CDSCO.
Named Patient Import allows patients or healthcare providers in India to legally import unapproved or investigational medicines from overseas, on a case-by-case basis, with necessary regulatory approvals from CDSCO.
This program is especially crucial for accessing life-saving treatments when no alternative therapies are available domestically.
Stay updated on pharma trends and marketplace opportunities.